nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP3A5—Disulfiram—alcohol dependence	0.155	0.238	CbGbCtD
Nevirapine—CYP2B6—Citalopram—alcohol dependence	0.14	0.215	CbGbCtD
Nevirapine—CYP2C9—Disulfiram—alcohol dependence	0.104	0.159	CbGbCtD
Nevirapine—CYP1A2—Citalopram—alcohol dependence	0.082	0.126	CbGbCtD
Nevirapine—CYP2D6—Citalopram—alcohol dependence	0.0676	0.104	CbGbCtD
Nevirapine—CYP3A4—Disulfiram—alcohol dependence	0.0603	0.0926	CbGbCtD
Nevirapine—CYP3A4—Citalopram—alcohol dependence	0.043	0.066	CbGbCtD
Nevirapine—Hepatitis fulminant—Disulfiram—alcohol dependence	0.0185	0.0921	CcSEcCtD
Nevirapine—Hepatic necrosis—Disulfiram—alcohol dependence	0.00696	0.0346	CcSEcCtD
Nevirapine—Surgical intervention—Citalopram—alcohol dependence	0.0057	0.0284	CcSEcCtD
Nevirapine—Surgery—Citalopram—alcohol dependence	0.0057	0.0284	CcSEcCtD
Nevirapine—Hepatitis fulminant—Citalopram—alcohol dependence	0.00547	0.0272	CcSEcCtD
Nevirapine—Rash papular—Naltrexone—alcohol dependence	0.00506	0.0252	CcSEcCtD
Nevirapine—Ache—Naltrexone—alcohol dependence	0.00408	0.0203	CcSEcCtD
Nevirapine—Hepatic failure—Disulfiram—alcohol dependence	0.00327	0.0163	CcSEcCtD
Nevirapine—Hepatitis cholestatic—Citalopram—alcohol dependence	0.00296	0.0147	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Citalopram—alcohol dependence	0.00259	0.0129	CcSEcCtD
Nevirapine—Hepatotoxicity—Naltrexone—alcohol dependence	0.00244	0.0121	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.00229	0.0114	CcSEcCtD
Nevirapine—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00222	0.011	CcSEcCtD
Nevirapine—Jaundice—Disulfiram—alcohol dependence	0.0022	0.011	CcSEcCtD
Nevirapine—Hepatic necrosis—Citalopram—alcohol dependence	0.00205	0.0102	CcSEcCtD
Nevirapine—Hepatitis—Disulfiram—alcohol dependence	0.00203	0.0101	CcSEcCtD
Nevirapine—Hypercholesterolaemia—Naltrexone—alcohol dependence	0.00199	0.00991	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Naltrexone—alcohol dependence	0.00199	0.00991	CcSEcCtD
Nevirapine—Ulcer—Naltrexone—alcohol dependence	0.00199	0.00991	CcSEcCtD
Nevirapine—Blood pressure increased—Naltrexone—alcohol dependence	0.00188	0.00938	CcSEcCtD
Nevirapine—Breast enlargement—Citalopram—alcohol dependence	0.00184	0.00916	CcSEcCtD
Nevirapine—Rash maculo-papular—Acamprosate—alcohol dependence	0.00181	0.00901	CcSEcCtD
Nevirapine—Mouth ulceration—Acamprosate—alcohol dependence	0.0018	0.00896	CcSEcCtD
Nevirapine—Lymphadenopathy—Acamprosate—alcohol dependence	0.00169	0.00843	CcSEcCtD
Nevirapine—Lymphadenopathy—Naltrexone—alcohol dependence	0.0016	0.00798	CcSEcCtD
Nevirapine—Rash erythematous—Citalopram—alcohol dependence	0.00156	0.00776	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00153	0.00762	CcSEcCtD
Nevirapine—Dermatitis bullous—Acamprosate—alcohol dependence	0.00151	0.00753	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00145	0.00722	CcSEcCtD
Nevirapine—Face oedema—Acamprosate—alcohol dependence	0.0014	0.00694	CcSEcCtD
Nevirapine—Rhabdomyolysis—Citalopram—alcohol dependence	0.00135	0.00671	CcSEcCtD
Nevirapine—Liver function test abnormal—Acamprosate—alcohol dependence	0.00133	0.00664	CcSEcCtD
Nevirapine—Bone disorder—Citalopram—alcohol dependence	0.00132	0.00658	CcSEcCtD
Nevirapine—Face oedema—Naltrexone—alcohol dependence	0.00132	0.00657	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.0013	0.00648	CcSEcCtD
Nevirapine—Paraesthesia—Disulfiram—alcohol dependence	0.0013	0.00645	CcSEcCtD
Nevirapine—Drug interaction—Citalopram—alcohol dependence	0.00129	0.0064	CcSEcCtD
Nevirapine—Somnolence—Disulfiram—alcohol dependence	0.00128	0.00638	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00127	0.00634	CcSEcCtD
Nevirapine—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00126	0.00628	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00126	0.00628	CcSEcCtD
Nevirapine—Fatigue—Disulfiram—alcohol dependence	0.00124	0.00619	CcSEcCtD
Nevirapine—Eosinophilia—Acamprosate—alcohol dependence	0.00124	0.00616	CcSEcCtD
Nevirapine—Pain—Disulfiram—alcohol dependence	0.00123	0.00614	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00123	0.00613	CcSEcCtD
Nevirapine—Pancreatitis—Acamprosate—alcohol dependence	0.00122	0.0061	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00121	0.006	CcSEcCtD
Nevirapine—Blood pressure increased—Citalopram—alcohol dependence	0.00119	0.00594	CcSEcCtD
Nevirapine—Hyperglycaemia—Acamprosate—alcohol dependence	0.00113	0.00561	CcSEcCtD
Nevirapine—Rash maculo-papular—Citalopram—alcohol dependence	0.00109	0.0054	CcSEcCtD
Nevirapine—Mouth ulceration—Citalopram—alcohol dependence	0.00108	0.00537	CcSEcCtD
Nevirapine—Asthenia—Disulfiram—alcohol dependence	0.00103	0.00515	CcSEcCtD
Nevirapine—Conjunctivitis—Naltrexone—alcohol dependence	0.00102	0.0051	CcSEcCtD
Nevirapine—Lymphadenopathy—Citalopram—alcohol dependence	0.00102	0.00505	CcSEcCtD
Nevirapine—Hepatitis—Acamprosate—alcohol dependence	0.001	0.00498	CcSEcCtD
Nevirapine—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000997	0.00496	CcSEcCtD
Nevirapine—Hepatic failure—Citalopram—alcohol dependence	0.000964	0.0048	CcSEcCtD
Nevirapine—Hepatitis—Naltrexone—alcohol dependence	0.000946	0.00471	CcSEcCtD
Nevirapine—Connective tissue disorder—Naltrexone—alcohol dependence	0.00093	0.00463	CcSEcCtD
Nevirapine—Rash—Disulfiram—alcohol dependence	0.000909	0.00453	CcSEcCtD
Nevirapine—Dermatitis bullous—Citalopram—alcohol dependence	0.000907	0.00451	CcSEcCtD
Nevirapine—Headache—Disulfiram—alcohol dependence	0.000904	0.0045	CcSEcCtD
Nevirapine—Immune system disorder—Acamprosate—alcohol dependence	0.000903	0.0045	CcSEcCtD
Nevirapine—Immune system disorder—Naltrexone—alcohol dependence	0.000855	0.00425	CcSEcCtD
Nevirapine—Face oedema—Citalopram—alcohol dependence	0.000837	0.00416	CcSEcCtD
Nevirapine—Ill-defined disorder—Acamprosate—alcohol dependence	0.000808	0.00402	CcSEcCtD
Nevirapine—Anaemia—Acamprosate—alcohol dependence	0.000805	0.004	CcSEcCtD
Nevirapine—Liver function test abnormal—Citalopram—alcohol dependence	0.0008	0.00398	CcSEcCtD
Nevirapine—Angioedema—Acamprosate—alcohol dependence	0.000795	0.00396	CcSEcCtD
Nevirapine—Malaise—Acamprosate—alcohol dependence	0.000785	0.00391	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00078	0.00388	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00078	0.00388	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000764	0.0038	CcSEcCtD
Nevirapine—Ill-defined disorder—Naltrexone—alcohol dependence	0.000764	0.0038	CcSEcCtD
Nevirapine—Angioedema—Naltrexone—alcohol dependence	0.000753	0.00375	CcSEcCtD
Nevirapine—Malaise—Naltrexone—alcohol dependence	0.000743	0.0037	CcSEcCtD
Nevirapine—Eosinophilia—Citalopram—alcohol dependence	0.000742	0.00369	CcSEcCtD
Nevirapine—Myalgia—Acamprosate—alcohol dependence	0.000741	0.00369	CcSEcCtD
Nevirapine—Arthralgia—Acamprosate—alcohol dependence	0.000741	0.00369	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000736	0.00366	CcSEcCtD
Nevirapine—Pancreatitis—Citalopram—alcohol dependence	0.000734	0.00365	CcSEcCtD
Nevirapine—Discomfort—Acamprosate—alcohol dependence	0.000732	0.00364	CcSEcCtD
Nevirapine—Anaphylactic shock—Acamprosate—alcohol dependence	0.00071	0.00354	CcSEcCtD
Nevirapine—Arthralgia—Naltrexone—alcohol dependence	0.000701	0.00349	CcSEcCtD
Nevirapine—Myalgia—Naltrexone—alcohol dependence	0.000701	0.00349	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000696	0.00347	CcSEcCtD
Nevirapine—Thrombocytopenia—Acamprosate—alcohol dependence	0.000696	0.00346	CcSEcCtD
Nevirapine—Discomfort—Naltrexone—alcohol dependence	0.000693	0.00345	CcSEcCtD
Nevirapine—Skin disorder—Acamprosate—alcohol dependence	0.00069	0.00343	CcSEcCtD
Nevirapine—Anorexia—Acamprosate—alcohol dependence	0.000677	0.00337	CcSEcCtD
Nevirapine—Hyperglycaemia—Citalopram—alcohol dependence	0.000676	0.00336	CcSEcCtD
Nevirapine—Anaphylactic shock—Naltrexone—alcohol dependence	0.000672	0.00335	CcSEcCtD
Nevirapine—Oedema—Naltrexone—alcohol dependence	0.000672	0.00335	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000662	0.00329	CcSEcCtD
Nevirapine—Nervous system disorder—Naltrexone—alcohol dependence	0.000659	0.00328	CcSEcCtD
Nevirapine—Neuropathy peripheral—Citalopram—alcohol dependence	0.000655	0.00326	CcSEcCtD
Nevirapine—Skin disorder—Naltrexone—alcohol dependence	0.000653	0.00325	CcSEcCtD
Nevirapine—Jaundice—Citalopram—alcohol dependence	0.000651	0.00324	CcSEcCtD
Nevirapine—Conjunctivitis—Citalopram—alcohol dependence	0.000649	0.00323	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000647	0.00322	CcSEcCtD
Nevirapine—Anorexia—Naltrexone—alcohol dependence	0.000641	0.00319	CcSEcCtD
Nevirapine—Paraesthesia—Acamprosate—alcohol dependence	0.000638	0.00317	CcSEcCtD
Nevirapine—Somnolence—Acamprosate—alcohol dependence	0.000632	0.00314	CcSEcCtD
Nevirapine—Hepatobiliary disease—Citalopram—alcohol dependence	0.000632	0.00314	CcSEcCtD
Nevirapine—Agranulocytosis—Citalopram—alcohol dependence	0.000623	0.0031	CcSEcCtD
Nevirapine—Decreased appetite—Acamprosate—alcohol dependence	0.000618	0.00307	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000613	0.00305	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000612	0.00305	CcSEcCtD
Nevirapine—Pain—Acamprosate—alcohol dependence	0.000608	0.00302	CcSEcCtD
Nevirapine—Paraesthesia—Naltrexone—alcohol dependence	0.000604	0.003	CcSEcCtD
Nevirapine—Hepatitis—Citalopram—alcohol dependence	0.0006	0.00298	CcSEcCtD
Nevirapine—Somnolence—Naltrexone—alcohol dependence	0.000598	0.00297	CcSEcCtD
Nevirapine—Connective tissue disorder—Citalopram—alcohol dependence	0.000589	0.00293	CcSEcCtD
Nevirapine—Feeling abnormal—Acamprosate—alcohol dependence	0.000585	0.00291	CcSEcCtD
Nevirapine—Decreased appetite—Naltrexone—alcohol dependence	0.000584	0.00291	CcSEcCtD
Nevirapine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000581	0.00289	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00058	0.00289	CcSEcCtD
Nevirapine—Fatigue—Naltrexone—alcohol dependence	0.00058	0.00288	CcSEcCtD
Nevirapine—Pain—Naltrexone—alcohol dependence	0.000575	0.00286	CcSEcCtD
Nevirapine—Erythema multiforme—Citalopram—alcohol dependence	0.000567	0.00282	CcSEcCtD
Nevirapine—Urticaria—Acamprosate—alcohol dependence	0.000564	0.00281	CcSEcCtD
Nevirapine—Abdominal pain—Acamprosate—alcohol dependence	0.000562	0.0028	CcSEcCtD
Nevirapine—Body temperature increased—Acamprosate—alcohol dependence	0.000562	0.0028	CcSEcCtD
Nevirapine—Feeling abnormal—Naltrexone—alcohol dependence	0.000554	0.00276	CcSEcCtD
Nevirapine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00055	0.00274	CcSEcCtD
Nevirapine—Immune system disorder—Citalopram—alcohol dependence	0.000542	0.00269	CcSEcCtD
Nevirapine—Urticaria—Naltrexone—alcohol dependence	0.000534	0.00266	CcSEcCtD
Nevirapine—Body temperature increased—Naltrexone—alcohol dependence	0.000531	0.00264	CcSEcCtD
Nevirapine—Abdominal pain—Naltrexone—alcohol dependence	0.000531	0.00264	CcSEcCtD
Nevirapine—Hypersensitivity—Acamprosate—alcohol dependence	0.000523	0.0026	CcSEcCtD
Nevirapine—Erythema—Citalopram—alcohol dependence	0.000522	0.0026	CcSEcCtD
Nevirapine—Asthenia—Acamprosate—alcohol dependence	0.00051	0.00254	CcSEcCtD
Nevirapine—Pruritus—Acamprosate—alcohol dependence	0.000503	0.0025	CcSEcCtD
Nevirapine—Hypersensitivity—Naltrexone—alcohol dependence	0.000495	0.00246	CcSEcCtD
Nevirapine—Diarrhoea—Acamprosate—alcohol dependence	0.000486	0.00242	CcSEcCtD
Nevirapine—Ill-defined disorder—Citalopram—alcohol dependence	0.000484	0.00241	CcSEcCtD
Nevirapine—Anaemia—Citalopram—alcohol dependence	0.000482	0.0024	CcSEcCtD
Nevirapine—Asthenia—Naltrexone—alcohol dependence	0.000482	0.0024	CcSEcCtD
Nevirapine—Angioedema—Citalopram—alcohol dependence	0.000477	0.00237	CcSEcCtD
Nevirapine—Pruritus—Naltrexone—alcohol dependence	0.000476	0.00237	CcSEcCtD
Nevirapine—Malaise—Citalopram—alcohol dependence	0.000471	0.00234	CcSEcCtD
Nevirapine—Diarrhoea—Naltrexone—alcohol dependence	0.00046	0.00229	CcSEcCtD
Nevirapine—Vomiting—Acamprosate—alcohol dependence	0.000452	0.00225	CcSEcCtD
Nevirapine—Rash—Acamprosate—alcohol dependence	0.000448	0.00223	CcSEcCtD
Nevirapine—Dermatitis—Acamprosate—alcohol dependence	0.000448	0.00223	CcSEcCtD
Nevirapine—Headache—Acamprosate—alcohol dependence	0.000445	0.00222	CcSEcCtD
Nevirapine—Arthralgia—Citalopram—alcohol dependence	0.000444	0.00221	CcSEcCtD
Nevirapine—Myalgia—Citalopram—alcohol dependence	0.000444	0.00221	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000441	0.0022	CcSEcCtD
Nevirapine—Discomfort—Citalopram—alcohol dependence	0.000439	0.00218	CcSEcCtD
Nevirapine—Vomiting—Naltrexone—alcohol dependence	0.000427	0.00213	CcSEcCtD
Nevirapine—Anaphylactic shock—Citalopram—alcohol dependence	0.000426	0.00212	CcSEcCtD
Nevirapine—Oedema—Citalopram—alcohol dependence	0.000426	0.00212	CcSEcCtD
Nevirapine—Rash—Naltrexone—alcohol dependence	0.000424	0.00211	CcSEcCtD
Nevirapine—Dermatitis—Naltrexone—alcohol dependence	0.000423	0.00211	CcSEcCtD
Nevirapine—Nausea—Acamprosate—alcohol dependence	0.000422	0.0021	CcSEcCtD
Nevirapine—Headache—Naltrexone—alcohol dependence	0.000421	0.0021	CcSEcCtD
Nevirapine—Nervous system disorder—Citalopram—alcohol dependence	0.000418	0.00208	CcSEcCtD
Nevirapine—Thrombocytopenia—Citalopram—alcohol dependence	0.000417	0.00208	CcSEcCtD
Nevirapine—Skin disorder—Citalopram—alcohol dependence	0.000414	0.00206	CcSEcCtD
Nevirapine—Anorexia—Citalopram—alcohol dependence	0.000406	0.00202	CcSEcCtD
Nevirapine—Nausea—Naltrexone—alcohol dependence	0.000399	0.00199	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000388	0.00193	CcSEcCtD
Nevirapine—Paraesthesia—Citalopram—alcohol dependence	0.000382	0.0019	CcSEcCtD
Nevirapine—Somnolence—Citalopram—alcohol dependence	0.000379	0.00188	CcSEcCtD
Nevirapine—Decreased appetite—Citalopram—alcohol dependence	0.00037	0.00184	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000368	0.00183	CcSEcCtD
Nevirapine—Fatigue—Citalopram—alcohol dependence	0.000367	0.00183	CcSEcCtD
Nevirapine—Pain—Citalopram—alcohol dependence	0.000364	0.00181	CcSEcCtD
Nevirapine—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.000357	0.00248	CbGpPWpGaD
Nevirapine—Feeling abnormal—Citalopram—alcohol dependence	0.000351	0.00175	CcSEcCtD
Nevirapine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000348	0.00173	CcSEcCtD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000344	0.00238	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—ADH7—alcohol dependence	0.000342	0.00237	CbGpPWpGaD
Nevirapine—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.00034	0.00236	CbGpPWpGaD
Nevirapine—Urticaria—Citalopram—alcohol dependence	0.000338	0.00168	CcSEcCtD
Nevirapine—Abdominal pain—Citalopram—alcohol dependence	0.000337	0.00168	CcSEcCtD
Nevirapine—Body temperature increased—Citalopram—alcohol dependence	0.000337	0.00168	CcSEcCtD
Nevirapine—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.000336	0.00233	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000334	0.00232	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000332	0.0023	CbGpPWpGaD
Nevirapine—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.00033	0.00229	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000329	0.00228	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—GGT2—alcohol dependence	0.000328	0.00227	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000326	0.00226	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000325	0.00225	CbGpPWpGaD
Nevirapine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000324	0.00225	CbGpPWpGaD
Nevirapine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000324	0.00225	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000322	0.00223	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.00032	0.00222	CbGpPWpGaD
Nevirapine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000318	0.0022	CbGpPWpGaD
Nevirapine—Hypersensitivity—Citalopram—alcohol dependence	0.000314	0.00156	CcSEcCtD
Nevirapine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000311	0.00215	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—MAOB—alcohol dependence	0.000308	0.00213	CbGpPWpGaD
Nevirapine—Asthenia—Citalopram—alcohol dependence	0.000306	0.00152	CcSEcCtD
Nevirapine—Pruritus—Citalopram—alcohol dependence	0.000301	0.0015	CcSEcCtD
Nevirapine—CYP2B6—Biological oxidations—ADH1B—alcohol dependence	0.0003	0.00208	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.000293	0.00203	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000292	0.00203	CbGpPWpGaD
Nevirapine—Diarrhoea—Citalopram—alcohol dependence	0.000291	0.00145	CcSEcCtD
Nevirapine—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000287	0.00199	CbGpPWpGaD
Nevirapine—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000286	0.00198	CbGpPWpGaD
Nevirapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000281	0.00195	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000279	0.00194	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.000278	0.00193	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000277	0.00192	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000276	0.00192	CbGpPWpGaD
Nevirapine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000276	0.00191	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000275	0.00191	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000274	0.0019	CbGpPWpGaD
Nevirapine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000272	0.00189	CbGpPWpGaD
Nevirapine—Vomiting—Citalopram—alcohol dependence	0.000271	0.00135	CcSEcCtD
Nevirapine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00027	0.00187	CbGpPWpGaD
Nevirapine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000269	0.00186	CbGpPWpGaD
Nevirapine—Rash—Citalopram—alcohol dependence	0.000269	0.00134	CcSEcCtD
Nevirapine—Dermatitis—Citalopram—alcohol dependence	0.000268	0.00134	CcSEcCtD
Nevirapine—Headache—Citalopram—alcohol dependence	0.000267	0.00133	CcSEcCtD
Nevirapine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000267	0.00185	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—ALDH2—alcohol dependence	0.000262	0.00181	CbGpPWpGaD
Nevirapine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000261	0.00181	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—SLC6A4—alcohol dependence	0.000261	0.00181	CbGpPWpGaD
Nevirapine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00026	0.0018	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000259	0.0018	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000256	0.00178	CbGpPWpGaD
Nevirapine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000256	0.00177	CbGpPWpGaD
Nevirapine—Nausea—Citalopram—alcohol dependence	0.000253	0.00126	CcSEcCtD
Nevirapine—CYP2B6—Biological oxidations—MAOB—alcohol dependence	0.000248	0.00172	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000245	0.0017	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000243	0.00168	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000238	0.00165	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.000237	0.00164	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000236	0.00163	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000234	0.00162	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—SLC6A3—alcohol dependence	0.000232	0.00161	CbGpPWpGaD
Nevirapine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000231	0.0016	CbGpPWpGaD
Nevirapine—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000228	0.00158	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000228	0.00158	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000226	0.00157	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000221	0.00153	CbGpPWpGaD
Nevirapine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00022	0.00153	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—GGT1—alcohol dependence	0.000219	0.00152	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000219	0.00152	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000215	0.00149	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000212	0.00147	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—ALDH2—alcohol dependence	0.000211	0.00146	CbGpPWpGaD
Nevirapine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000211	0.00146	CbGpPWpGaD
Nevirapine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00021	0.00146	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—CYP2E1—alcohol dependence	0.000209	0.00145	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000208	0.00144	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000207	0.00143	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000206	0.00143	CbGpPWpGaD
Nevirapine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000205	0.00142	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.000201	0.0014	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.000193	0.00134	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—GGT1—alcohol dependence	0.000192	0.00133	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000187	0.0013	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000183	0.00127	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000182	0.00126	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000181	0.00125	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00018	0.00125	CbGpPWpGaD
Nevirapine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000178	0.00124	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000176	0.00122	CbGpPWpGaD
Nevirapine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000176	0.00122	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000173	0.0012	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—MAOA—alcohol dependence	0.000172	0.00119	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000171	0.00119	CbGpPWpGaD
Nevirapine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00017	0.00118	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—CYP2E1—alcohol dependence	0.000169	0.00117	CbGpPWpGaD
Nevirapine—CYP2B6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000167	0.00115	CbGpPWpGaD
Nevirapine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000166	0.00115	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000165	0.00114	CbGpPWpGaD
Nevirapine—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000163	0.00113	CbGpPWpGaD
Nevirapine—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000156	0.00108	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000155	0.00108	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—GGT1—alcohol dependence	0.000155	0.00107	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000154	0.00107	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—GGT1—alcohol dependence	0.000151	0.00105	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000149	0.00103	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000147	0.00102	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000146	0.00101	CbGpPWpGaD
Nevirapine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000146	0.00101	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000146	0.00101	CbGpPWpGaD
Nevirapine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000145	0.001	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000144	0.001	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—MAOA—alcohol dependence	0.000139	0.000963	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000136	0.000944	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—MAOA—alcohol dependence	0.000136	0.000941	CbGpPWpGaD
Nevirapine—CYP2A6—liver—alcohol dependence	0.000136	0.0384	CbGeAlD
Nevirapine—CYP2A6—cerebellum—alcohol dependence	0.000132	0.0375	CbGeAlD
Nevirapine—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000124	0.000862	CbGpPWpGaD
Nevirapine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000124	0.000857	CbGpPWpGaD
Nevirapine—CYP2B6—adrenal cortex—alcohol dependence	0.000121	0.0343	CbGeAlD
Nevirapine—CYP2A6—Metabolism—ADH6—alcohol dependence	0.000121	0.000838	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000119	0.000824	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000118	0.00082	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000117	0.000814	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000117	0.000813	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000116	0.000806	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000116	0.000802	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000115	0.000795	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000113	0.000782	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—POMC—alcohol dependence	0.000112	0.000777	CbGpPWpGaD
Nevirapine—CYP2B6—cardiovascular system—alcohol dependence	0.00011	0.0313	CbGeAlD
Nevirapine—CYP2C9—cardiovascular system—alcohol dependence	0.000109	0.031	CbGeAlD
Nevirapine—CYP3A5—pancreas—alcohol dependence	0.000108	0.0306	CbGeAlD
Nevirapine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000108	0.000747	CbGpPWpGaD
Nevirapine—CYP2A6—brain—alcohol dependence	0.000108	0.0305	CbGeAlD
Nevirapine—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000107	0.00074	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000101	0.000703	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000101	0.000703	CbGpPWpGaD
Nevirapine—CYP2D6—brainstem—alcohol dependence	0.000101	0.0285	CbGeAlD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.0001	0.000695	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ADH1A—alcohol dependence	0.0001	0.000695	CbGpPWpGaD
Nevirapine—CYP2B6—gonad—alcohol dependence	0.0001	0.0284	CbGeAlD
Nevirapine—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	9.94e-05	0.000689	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	9.8e-05	0.00068	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ADH6—alcohol dependence	9.76e-05	0.000677	CbGpPWpGaD
Nevirapine—CYP2D6—forebrain—alcohol dependence	9.7e-05	0.0275	CbGeAlD
Nevirapine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	9.65e-05	0.000669	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	9.6e-05	0.000665	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—MAOA—alcohol dependence	9.57e-05	0.000664	CbGpPWpGaD
Nevirapine—CYP1A2—digestive system—alcohol dependence	9.56e-05	0.0271	CbGeAlD
Nevirapine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	9.54e-05	0.000662	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ADH6—alcohol dependence	9.54e-05	0.000661	CbGpPWpGaD
Nevirapine—CYP3A5—digestive system—alcohol dependence	9.22e-05	0.0261	CbGeAlD
Nevirapine—CYP2B6—digestive system—alcohol dependence	9.16e-05	0.026	CbGeAlD
Nevirapine—CYP1A2—Biological oxidations—GGT1—alcohol dependence	9.13e-05	0.000633	CbGpPWpGaD
Nevirapine—CYP1A2—blood—alcohol dependence	9.11e-05	0.0258	CbGeAlD
Nevirapine—CYP2C9—digestive system—alcohol dependence	9.08e-05	0.0257	CbGeAlD
Nevirapine—CYP2B6—Biological oxidations—POMC—alcohol dependence	9.04e-05	0.000627	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—POMC—alcohol dependence	8.84e-05	0.000613	CbGpPWpGaD
Nevirapine—CYP3A5—blood—alcohol dependence	8.78e-05	0.0249	CbGeAlD
Nevirapine—CYP2B6—blood—alcohol dependence	8.73e-05	0.0247	CbGeAlD
Nevirapine—CYP2C9—blood—alcohol dependence	8.65e-05	0.0245	CbGeAlD
Nevirapine—CYP2A6—Metabolism—ADH4—alcohol dependence	8.52e-05	0.000591	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—MAOA—alcohol dependence	8.18e-05	0.000567	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ADH1A—alcohol dependence	8.09e-05	0.000561	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ADH1A—alcohol dependence	7.9e-05	0.000548	CbGpPWpGaD
Nevirapine—CYP1A2—endocrine gland—alcohol dependence	7.9e-05	0.0224	CbGeAlD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.74e-05	0.000536	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	7.67e-05	0.000532	CbGpPWpGaD
Nevirapine—CYP3A5—endocrine gland—alcohol dependence	7.62e-05	0.0216	CbGeAlD
Nevirapine—CYP2B6—endocrine gland—alcohol dependence	7.57e-05	0.0215	CbGeAlD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	7.57e-05	0.000525	CbGpPWpGaD
Nevirapine—CYP2C9—endocrine gland—alcohol dependence	7.5e-05	0.0213	CbGeAlD
Nevirapine—CYP2A6—Metabolism—ADH7—alcohol dependence	7.24e-05	0.000502	CbGpPWpGaD
Nevirapine—CYP2B6—testis—alcohol dependence	7.22e-05	0.0205	CbGeAlD
Nevirapine—CYP1A2—liver—alcohol dependence	7.12e-05	0.0202	CbGeAlD
Nevirapine—CYP2B6—nervous system—alcohol dependence	7.09e-05	0.0201	CbGeAlD
Nevirapine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	7.04e-05	0.000488	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GGT2—alcohol dependence	6.95e-05	0.000482	CbGpPWpGaD
Nevirapine—CYP3A4—digestive system—alcohol dependence	6.92e-05	0.0196	CbGeAlD
Nevirapine—CYP2B6—Metabolism—ADH4—alcohol dependence	6.87e-05	0.000477	CbGpPWpGaD
Nevirapine—CYP3A5—liver—alcohol dependence	6.87e-05	0.0195	CbGeAlD
Nevirapine—CYP2B6—liver—alcohol dependence	6.83e-05	0.0193	CbGeAlD
Nevirapine—CYP2B6—central nervous system—alcohol dependence	6.82e-05	0.0193	CbGeAlD
Nevirapine—CYP2D6—digestive system—alcohol dependence	6.81e-05	0.0193	CbGeAlD
Nevirapine—CYP2D6—Metabolism—ADH6—alcohol dependence	6.78e-05	0.00047	CbGpPWpGaD
Nevirapine—CYP2C9—liver—alcohol dependence	6.76e-05	0.0192	CbGeAlD
Nevirapine—CYP2C9—Metabolism—ADH6—alcohol dependence	6.72e-05	0.000466	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ADH4—alcohol dependence	6.72e-05	0.000466	CbGpPWpGaD
Nevirapine—CYP3A4—blood—alcohol dependence	6.59e-05	0.0187	CbGeAlD
Nevirapine—CYP2D6—blood—alcohol dependence	6.49e-05	0.0184	CbGeAlD
Nevirapine—CYP2A6—Metabolism—ADH1B—alcohol dependence	6.35e-05	0.00044	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	6.31e-05	0.000438	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—POMC—alcohol dependence	6.29e-05	0.000436	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—POMC—alcohol dependence	6.23e-05	0.000432	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ADH7—alcohol dependence	5.85e-05	0.000405	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADH6—alcohol dependence	5.75e-05	0.000398	CbGpPWpGaD
Nevirapine—CYP3A4—endocrine gland—alcohol dependence	5.72e-05	0.0162	CbGeAlD
Nevirapine—CYP3A5—Metabolism—ADH7—alcohol dependence	5.71e-05	0.000396	CbGpPWpGaD
Nevirapine—CYP2D6—endocrine gland—alcohol dependence	5.63e-05	0.0159	CbGeAlD
Nevirapine—CYP2D6—Metabolism—ADH1A—alcohol dependence	5.62e-05	0.00039	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GGT2—alcohol dependence	5.6e-05	0.000389	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADH1A—alcohol dependence	5.57e-05	0.000386	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GGT2—alcohol dependence	5.48e-05	0.00038	CbGpPWpGaD
Nevirapine—CYP2B6—brain—alcohol dependence	5.42e-05	0.0154	CbGeAlD
Nevirapine—CYP2D6—testis—alcohol dependence	5.37e-05	0.0152	CbGeAlD
Nevirapine—CYP3A4—nervous system—alcohol dependence	5.35e-05	0.0152	CbGeAlD
Nevirapine—CYP1A2—Biological oxidations—POMC—alcohol dependence	5.32e-05	0.000369	CbGpPWpGaD
Nevirapine—CYP2D6—nervous system—alcohol dependence	5.27e-05	0.0149	CbGeAlD
Nevirapine—CYP2A6—Metabolism—MAOB—alcohol dependence	5.26e-05	0.000365	CbGpPWpGaD
Nevirapine—CYP3A4—liver—alcohol dependence	5.16e-05	0.0146	CbGeAlD
Nevirapine—CYP3A4—central nervous system—alcohol dependence	5.15e-05	0.0146	CbGeAlD
Nevirapine—CYP2B6—Metabolism—ADH1B—alcohol dependence	5.13e-05	0.000355	CbGpPWpGaD
Nevirapine—CYP2D6—liver—alcohol dependence	5.07e-05	0.0144	CbGeAlD
Nevirapine—CYP2D6—central nervous system—alcohol dependence	5.07e-05	0.0144	CbGeAlD
Nevirapine—CYP3A5—Metabolism—ADH1B—alcohol dependence	5.01e-05	0.000347	CbGpPWpGaD
Nevirapine—CYP2D6—cerebellum—alcohol dependence	4.96e-05	0.014	CbGeAlD
Nevirapine—CYP2D6—Metabolism—ADH4—alcohol dependence	4.78e-05	0.000331	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADH1A—alcohol dependence	4.76e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADH4—alcohol dependence	4.74e-05	0.000328	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALDH2—alcohol dependence	4.48e-05	0.00031	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADH6—alcohol dependence	4.43e-05	0.000307	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MAOB—alcohol dependence	4.25e-05	0.000294	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MAOB—alcohol dependence	4.15e-05	0.000288	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—POMC—alcohol dependence	4.11e-05	0.000285	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	4.1e-05	0.000284	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADH7—alcohol dependence	4.06e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADH4—alcohol dependence	4.05e-05	0.000281	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADH7—alcohol dependence	4.03e-05	0.000279	CbGpPWpGaD
Nevirapine—CYP2D6—brain—alcohol dependence	4.03e-05	0.0114	CbGeAlD
Nevirapine—CYP2D6—Metabolism—GGT2—alcohol dependence	3.9e-05	0.00027	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GGT2—alcohol dependence	3.86e-05	0.000268	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GOT2—alcohol dependence	3.81e-05	0.000264	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADH1A—alcohol dependence	3.67e-05	0.000255	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALDH2—alcohol dependence	3.61e-05	0.00025	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2E1—alcohol dependence	3.58e-05	0.000248	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADH1B—alcohol dependence	3.56e-05	0.000247	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADH1B—alcohol dependence	3.53e-05	0.000245	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALDH2—alcohol dependence	3.53e-05	0.000245	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.5e-05	0.000243	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADH7—alcohol dependence	3.44e-05	0.000239	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GGT2—alcohol dependence	3.3e-05	0.000229	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GGT1—alcohol dependence	3.29e-05	0.000228	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GOT1—alcohol dependence	3.29e-05	0.000228	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADH4—alcohol dependence	3.12e-05	0.000217	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GOT2—alcohol dependence	3.07e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADH1B—alcohol dependence	3.02e-05	0.000209	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GOT2—alcohol dependence	3e-05	0.000208	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MAOB—alcohol dependence	2.95e-05	0.000205	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—MAOA—alcohol dependence	2.94e-05	0.000204	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MAOB—alcohol dependence	2.93e-05	0.000203	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2E1—alcohol dependence	2.89e-05	0.0002	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2E1—alcohol dependence	2.82e-05	0.000196	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADH7—alcohol dependence	2.66e-05	0.000184	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GGT1—alcohol dependence	2.65e-05	0.000184	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GOT1—alcohol dependence	2.65e-05	0.000184	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GGT1—alcohol dependence	2.59e-05	0.00018	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GOT1—alcohol dependence	2.59e-05	0.00018	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GGT2—alcohol dependence	2.55e-05	0.000177	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALDH2—alcohol dependence	2.51e-05	0.000174	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MAOB—alcohol dependence	2.5e-05	0.000173	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALDH2—alcohol dependence	2.49e-05	0.000173	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.39e-05	0.000166	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MAOA—alcohol dependence	2.38e-05	0.000165	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADH1B—alcohol dependence	2.33e-05	0.000161	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MAOA—alcohol dependence	2.32e-05	0.000161	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT2—alcohol dependence	2.13e-05	0.000148	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDH2—alcohol dependence	2.13e-05	0.000147	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT2—alcohol dependence	2.12e-05	0.000147	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.04e-05	0.000142	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	2.01e-05	0.000139	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1.99e-05	0.000138	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MAOB—alcohol dependence	1.93e-05	0.000134	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—POMC—alcohol dependence	1.92e-05	0.000133	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT1—alcohol dependence	1.84e-05	0.000128	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GGT1—alcohol dependence	1.84e-05	0.000128	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT1—alcohol dependence	1.83e-05	0.000127	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GGT1—alcohol dependence	1.83e-05	0.000127	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT2—alcohol dependence	1.81e-05	0.000125	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	1.7e-05	0.000118	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MAOA—alcohol dependence	1.65e-05	0.000114	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.64e-05	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MAOA—alcohol dependence	1.64e-05	0.000113	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.59e-05	0.00011	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GGT1—alcohol dependence	1.56e-05	0.000108	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT1—alcohol dependence	1.56e-05	0.000108	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—POMC—alcohol dependence	1.55e-05	0.000107	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—POMC—alcohol dependence	1.51e-05	0.000105	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MAOA—alcohol dependence	1.4e-05	9.7e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT2—alcohol dependence	1.4e-05	9.67e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.36e-05	9.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.31e-05	9.1e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—EP300—alcohol dependence	1.27e-05	8.82e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GGT1—alcohol dependence	1.2e-05	8.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT1—alcohol dependence	1.2e-05	8.35e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MAOA—alcohol dependence	1.08e-05	7.48e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—POMC—alcohol dependence	1.07e-05	7.45e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—POMC—alcohol dependence	1.07e-05	7.39e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—EP300—alcohol dependence	1.03e-05	7.11e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—EP300—alcohol dependence	1e-05	6.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—POMC—alcohol dependence	9.11e-06	6.31e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—EP300—alcohol dependence	7.13e-06	4.94e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—EP300—alcohol dependence	7.07e-06	4.9e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—POMC—alcohol dependence	7.03e-06	4.87e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—EP300—alcohol dependence	6.04e-06	4.19e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—EP300—alcohol dependence	4.66e-06	3.23e-05	CbGpPWpGaD
